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Histone lysine residues can be mono-, di-, or
trimethylated. These posttranslational modifi-
cations regulate the affinity of effector proteins
and may also impact chromatin structure inde-
pendent of their role as adaptors. In order to
study histone lysine methylation, particularly in
the context of chromatin, we have developed a
chemical approach to install analogs of methyl
lysine into recombinant proteins. This approach
allows for the rapid generation of large quanti-
ties of histones in which the site and degree of
methylation can be specified. We demonstrate
that these methyl-lysine analogs (MLAs) are
functionally similar to their natural counterparts.
These methylated histones were used to exam-
ine the influence of specific lysine methylation
on the binding of effecter proteins and the rates
of nucleosome remodeling. This simple method
of introducing site-specific and degree-specific
methylation into recombinant histones provides
a powerful tool to investigate the biochemical
mechanisms by which lysine methylation influ-
ences chromatin structure and function.
INTRODUCTION
Cell-type specificity in multicellular organisms is an epige-
netic phenomenon. Studies in model organisms implicate
histone lysine methylation as particularly important for de-
fining the epigenetic status of a cell. The 3-amine of lysine
is subject to mono-, di-, or trimethylation. Each methyla-
tion state may have a distinct regulatory impact through
modulating the binding of different effector proteins
(Martin and Zhang, 2005; Sims et al., 2003). Consistent
with this notion, plant homeodomains (PHD) in the NURFremodeling complex and in the tumor suppressor ING2
bind with specificity for trimethylated over dimethylated
Lys4 of histone H3 (Li et al., 2006; Pena et al., 2006; Shi
et al., 2006; Wysocka et al., 2006). The functional conse-
quences of lysine methylation, in addition to being degree
dependant, are also determined by the site of methylation
(Lachner et al., 2003). For example, while trimethylation at
Lys4 is associated with euchromatin and transcriptional
activation (Santos-Rosa et al., 2002), trimethylation of
H3 Lys9 is a well-established marker of heterochromatin
and associated with transcriptional repression (Lee et al.,
2005; Rea et al., 2000).
Recent years have seen the identification of numerous
enzymes responsible for lysine methylation and demethy-
lation, as well as downstream effectors that bind to spe-
cific methyl-lysine residues in histones (Grewal and
Moazed, 2003; Martin and Zhang, 2005). For instance,
the Lys9-specific methyltransferase SUV39H1 (in addition
to its orthologs in other organisms) has been implicated in
transcriptional silencing (Ivanova et al., 1998; Rea et al.,
2000) and interacts genetically and biochemically with
the heterochromatin-associated protein HP1a (and its or-
thologs). Indeed, Lys9 methylation is recognized by the
chromodomain of HP1a, which itself recruits SUV39H1
and is believed to oligomerize, causing a repressive chro-
matin structure by spreading along the chromatin (Grewal
and Moazed, 2003).
Methyl-lysine residues in nucleosomal histones are hy-
pothesized to mediate interactions with themacromolecu-
lar complexes that regulate transcription, replication, and
DNA repair. Investigating how lysine modifications influ-
ence the activity of these factors would be facilitated by
a biochemical system that allows testing of specific meth-
ylation patterns on any histone. In particular, nucleosomes
reconstituted fromhomogeneouspreparationsof recombi-
nant histones, ideally with every possiblemethylation state
at eachsite of interest,would allowsystematic examination
of the events downstream of lysine methylation.
In order to develop such a system,we sought an efficient
means to reconstitute nucleosomes with site-specificCell 128, 1003–1012, March 9, 2007 ª2007 Elsevier Inc. 1003
mono-, di- and trimethylation at positions throughout
the entire sequence of each histone. Current methods to
introduce methylation into recombinant histones include
biosynthetic approaches or semisynthesis. The use of en-
zymes to methylate lysine residues is limited by the avail-
ability of specific methyltransferases. Even in cases where
an appropriate methyltransferase is available, these reac-
tions are difficult to drive to completion and can lead to
uncontrolled degrees of methylation or heterogeneity
with respect to site specificity.
Semisynthetic methods to construct modified histones
using native chemical ligation have been reported (He
et al., 2003; Shogren-Knaak et al., 2003; Shogren-Knaak
and Peterson, 2004). This approach was instrumental in
demonstrating a role for H4 Lys16 acetylation in antago-
nizing chromatin compaction (Shogren-Knaak et al.,
2006), underscoring the utility of homogeneously modified
histones for investigating the impact of lysine modifica-
tions on chromatin function. Nonetheless, the semisyn-
thesis of modified histones is currently limited tomodifica-
tions at only N-terminal residues (residues 1–30) and
requires the synthesis of large quantities of modified pep-
tide thioesters.
As an alternative to existing methods, we hypothesized
that it would be possible exploit the latent reactivity of nat-
ural amino acid side chains to chemically generate his-
toneswith site- and degree-specificmethylation.Methods
to chemically methylate lysine residues, such as reductive
alkylation (Means and Feeney, 1968), are not amenable to
controlling which of the numerous histone-lysine residues
are modified. Direct site-specific methylation of lysine res-
idues does not appear to be a tractable solution. Cysteine
is an attractive target for chemical elaboration due to its
distinctive reactivity as a nucleophile. We were inspired
by reports dating back half a century regarding the amino-
ethylation reaction: a cysteine, installed at the desired site
of modification, can be alkylated to create aminoethylcys-
teine, an analog of lysine (see Figure 1A, reviewed in
Kenyon and Bruice, 1977). Here, we report the extension
of the traditional aminoethylation reaction to introduce
N-methylated aminoethylcysteine residues (Figure 1B),
thereby allowing the installation of methyl lysine analogs
(MLAs). This scheme provides a simple and affordable
route to large quantities of specifically methylated his-
tones. TheMLA strategy is compatible with the installation
of modifications in the nucleosome core including histone
H3 Lys79–a modification that, even using state-of-the-art
semisynthesis strategies (Muralidharan and Muir, 2006),
would be extremely challenging to access. We demon-
strate that MLAs function similarly to their natural counter-
parts and are useful for the study of histone-lysine methyl-
ation’s influence on chromatin structure and function.
RESULTS
Design of MLAs
Aminoethylcysteine has proven useful as an analog of
lysine for chemical rescue and cysteine mapping applica-1004 Cell 128, 1003–1012, March 9, 2007 ª2007 Elsevier Inc.tions (Kenyon and Bruice, 1977). For example, a protein
that contains a cysteine can be alkylated with an electo-
phillic ethylamine, and the product (aminoethylcysteine,
see Figure 1A) can direct protealytic cleavage using a
lysine-directed protease such as trypsin (for early exam-
ples, see Raftery and Cole, 1966 and references therein).
Aminoethylcysteine is structurally and chemically similar
to lysine; substituting the lysine g-methylene with a sul-
fide causes only a slight lengthening of the side chain
(0.28 A˚), and the electron withdrawing effect of the
thioether causes only a small increase in the acidity
(1.1 pKa unit) of the ammonium protons (see Gloss and
Kirsch, 1995 and references therein).
Figure 1. The Installation of Methyl-Lysine Analogs into
Recombinant Proteins by Alkylating Cysteine Residues
(A) The MLA strategy is an extension of the traditional aminoethylation
reaction in which a cysteine is alkylated with an electrophilic ethyl-
amine producing aminoethylcysteine, an analog of lysine.
(B) Cysteine residues can be converted into analogs of mono-, di-,
and trimethylated lysine by treatment with alkylating agents 1-3,
respectively.
(C) Incubating 2 under basic conditions leads to aziridinium formation.
The resulting aziridinium can react with a cysteine residue leading to
the desired dimethyl lysine analog.
We reasoned that a related reaction would allow the in-
troduction of analogs of methyl lysine into recombinant
proteins. Indeed, the use of (2-bromoethyl)-trimethylam-
monium bromide (3) was developed as a reagent to block
cysteine residues (Itano and Robinson, 1972) but to our
knowledge has never been recognized as a useful analog
of trimethyl lysine. To develop other reagents that selec-
tively alkylate cysteine residues to generate MLAs, we ini-
tially synthesized 2-iodoethyl amines (data not shown).
While these reagents convert cysteine to the desired
MLAs, we found that the commercially available (2-hal-
oethyl) amines 1–3 (Figure 1B) were similarly able to effect
this conversion. While alkyl iodides are generally more re-
active than alkyl chlorides and bromides, the high reactiv-
ity of (2-cholorethyl)-dimethylammonium chloride (2) can
be attributed to an aziridinium intermediate formed under
the reaction conditions (Figure 1C). The formation of this
reactive intermediate decouples the rate-limiting step
(alkylation of the cysteine) from the leaving of the halide
leaving group. A similar mechanism has recently been
characterized for (2-bromoethyl) ammonium bromide
(Hopkins et al., 2005).
Fortuitously, the core nucleosome contains only a single
conserved cysteine (H3C110) that can be mutated to ala-
nine without disrupting nucleosome function. Therefore
a unique cysteine can be installed at any position (e.g.,
H4K20C or H3K79C in the background of a C110A muta-
tion) and, upon treatment with an appropriate alkylating
agent, the introduced cysteine can be converted into an
analog of monomethyl lysine, dimethyl lysine, or trimethyl
lysine. Given that N-substituted aminoethylcysteine resi-
dues are lysine (K) analogs derived from cysteine (C), we
refer to them with the abbreviation KC and otherwise
follow standard abbreviations (Turner, 2005) for histone
modifications (e.g., KC9me3).
Optimization of Conditions to Install MLAs
into Proteins
To determine whether the chemistry to install MLAs can
produce homogeneous products for biochemical analy-
sis, we used model cysteine-containing peptides to find
conditions that promote specificity for cysteine alkylation
over other nucleophilic side chains, minimize variability
caused by different sequence contexts, and proceed
with high conversion. Controlling the pH of the reaction
was critical. At pH < 7.5, cysteine residues are mostly
protonated, and the reactions proceeded sluggishly. At
pH > 8.5 side reactions were observed. However, reac-
tions performed with reagents 1–3 using optimized buffer
conditions, reaction time, temperature, and concentra-
tions of the alkylating agents afford good conversion
(>90%) of cysteine to the desired MLAs in the context of
a model peptide (Figure 2A).
Extending these conditions to convert cysteine to the
desired analogs in the context of full-length histones
rather than peptides required increasing the concentration
of denaturant (to increase the accessibility of cysteine res-
idues installed at core positions; see Figure S1A) andincluding freemethionine to prevent low levels of oxidation
observed in its absence (Figure S1B). With these improve-
ments, the reaction pH, concentration of alkylating agent,
time, and temperature were reoptimized to affordmaximal
conversion of cysteine residues to the desired MLAs
(Figure S1). By monitoring the reactions by ESI-oaTOF
mass spectrometry, these conditions were found to be ro-
bust, leading to high conversion without excessive alkyl-
ation (shown for histone H3K9C in Figure 2B). Although
a second peak at +42 ± 1 Daltons was routinely observed
in the product spectra, this peak was also observed in the
starting material and is attributable to a mass spectrome-
try artifact; examination of the products on other mass
spectrometers did not detect this contaminating species.
Comprehensive characterization of the proteins was
carried out using electron capture dissociation (ECD)
(Zubarev et al., 1998) of the intact H3 Lys9-modified his-
tones on a Fourier-transform ion cyclotron resonance
mass spectrometer (FT-ICR). Most of the observed peaks
in ECD spectra feature the N-terminal (c ions) and the C-
terminal (z ions) fragmentation ions. The fragment ion lad-
der around residue 9 (e.g., c6
2+, c7
2+, c8
2+, c9
3+, c10
3+;
Figure 2C) indicates complete and homogenous incorpo-
ration of the desired modifications on residue 9. When
comparing KC9me1, KC9me2, and KC9me3 histones, the
mass increment of the MLA-containing ions (colored in
magenta) equals the expected 14 amu, indicating they
aremono-, di-, and trimethylated, respectively (Figure 2C).
These reaction conditions were found to be robust lead-
ing to clean installation of methyl-lysine analogs at every
position that we have attempted to modify (see, for exam-
ple, the modification of histones H3 K4C, H3K36C, and
H4K20C shown in Figure S2). Given the routine bacterial
expression of large quantities of histone mutants (Luger
et al., 1999) and the low cost of alkylating reagents 1–3,
the MLA approach allows simple and economic access
to large quantities of near-homogeneously (>90%) meth-
ylated histones.
Functional Analysis of MLAs
Histone H3 methyl Lys9 analogs were used along with the
other core histones to reconstitute histone octamers
(Figure 3A, Coomassie). Not only could Lys9 analogs be
incorporated into histone ocatmers but also anti-sera
raised against natural mono-, di-, and trimethyl Lys9 spe-
cifically recognized the appropriate MLAs in western blots
(Figure 3A). The ability of antisera to recognize MLAs was
not limited to H3 Lys9; similar results were achieved at
other positions (H3 Lys4, H3 Lys36), including positions
in the nucleosome core (H3 Lys79) and on histone H4
(H4 Lys20) as shown in Figures 3B and 3C. Despite their
exquisite sensitivity to the presence or absence of a single
methyl group, these antibody preparations react strongly
with the appropriate MLAs, indicating that the MLA side
chains do not constitute a major perturbation to the natu-
ral methyl lysine epitopes, leading us to conclude that
MLAs and natural methyl lysine residues are not easily
distinguished in binding assays. In direct comparisonsCell 128, 1003–1012, March 9, 2007 ª2007 Elsevier Inc. 1005
Figure 2. Cysteine Residues Can Be Efficiently Converted into MLAs in the Context of Peptides and Full-Length Proteins
(A) A cysteine-containing peptide (Fluroesceine-KACR-OH) is converted to the desired lysine analog under optimized reaction conditions (see Exper-
imental Procedures) as observed by reverse phase HPLC analysis of the crude reaction products. The traces are for the starting peptide (Cys); the
unmethylated lysine analog, KC; the monomethylated lysine analog, KC(me1); the dimethylated lysine analog, KC(me2); and the trimethylated lysine
analog, KC(me3).
(B) Mass spectra (ESI-oaTOF) demonstrate that MLAs can be cleanly installed at position 9 of full-length histone H3 protein. Starting with a K9C
mutation (top left), this histone was treated under conditions to install analogs of monomethyl Lys9 H3 (top right), dimethyl Lys9 H3 (bottom left), or
trimethyl Lys9 H3 (bottom right). The asterisk indicates a peak at +42 daltons corresponding to an artifact and is present in both the starting material
and the methylated histone products.
(C) Representative ECD spectra of full-length histones acquired from a FT-ICR mass spectrometer are consistent with the installation of desired
analogs at histone H3 residue 9.between peptides bearing K9me2 and KC9me2, we found
that the antibody recognition was still specific, but that
KC9me2 lead to a5-fold weaker signal in a dot blot assay
relative to a K9me2 peptide (Figure S3).
To further probe the functional similarity between natu-
ral methylated lysine residues and MLAs, we examined
HP1 binding to Lys9 modifications. The structural pertur-
bation caused by replacing lysine g-methylene with a sul-
fide was addressed by modeling a KC9me2 peptide into
the crystal structure (Jacobs and Khorasanizadeh, 2002)
of the HP1 chromodomain bound to a K9me2 peptide
(Figure 4A). Theminimal differences observed in themodel
of the MLA peptide compared with the natural peptide
suggest the analog will bind similarly to HP1. To test this
model, synthetic peptides were used as affinity reagents
to enrich HP1a from a 293 nuclear extract (Figure 4B).
While a K9 peptide did not interact with HP1a, both a
K9me2 peptide and a KC9me2 peptide interacted strongly
with HP1a. This result with model peptides raised the1006 Cell 128, 1003–1012, March 9, 2007 ª2007 Elsevier Inc.possibility that MLAs should also be functionally useful
in the more complex case of MLA-bearing nucleosomes.
Indeed, upon incorporation into biotinylated nucleo-
somes, KC9me2 enhanced interactions between the
modified nucleosome and HP1a relative to an unmodified
nucleosome (Figure 4C).
We next usedmononucleosomes containing KC9me2 to
assay whether incorporation of MLA histones alters the
affinity of nucleosomes for proteins in which histone
methylation is not implicated in regulation of binding spec-
ificity. SUZ12 is important for nucleosome binding of the
Polycomb Repressive Complex 2, histone-methyltrans-
ferase complex (Nekrasov et al., 2005). In affinity studies,
SUZ12 did not distinguish between KC9me2 and wild-
type nucleosomes (Figure 4D), indicating that incorpora-
tion of MLA histones does not nonspecifically impair
nucleosome accessibility and suggesting that methylation
at Lys9 does not regulate SUZ12’s nucleosome binding
activity.
Figure 3. MLAs Can Be Incorporated into
Histone Octamers and Are Specifically
RecognizedbyAntibodiesRaisedagainst
the Corresponding Natural Modifications
(A) Western blot analysis of octamers assem-
bled with MLAs at position 9 of histone H3.
(B) Similar analysis with MLAs incorporated at
various core and tail positions.
(C) The positions of modifications in (A) and (B)
mapped onto a model of the nucleosome
(based on Luger et al., 1997).Histone H3 Lys9 methylation is implicated in regulation
of DNA methylation (Tamaru et al., 2003). We examined
whetherKC9me2-containing nucleosomesbound theDNA
methyltransferase DNMT1. This protein was not enriched
when pulling down with either Lys9-modified or -unmodi-
fied nucleosomes (Figure 4E).
AlthoughMLAs behave similarly to their natural counter-
parts in binding assays, the sensitivity of chemical cataly-
sis to small changes in the structure of the reaction’s tran-
sition state suggests that analog function in an enzymatic
assay is a more stringent criterion for similarity. To test
analog function in enzymatic reactions, peptides bearing
either lysine or lysine analogs were examined as sub-
strates for the Lys9-specific methyltransferase SUV39H1
(Figure 5A). In this assay, a peptide bearing aminoethyl-
cysteine was nearly as efficient a substrate for methylation
as an unmodified lysine peptide. Furthermore, K9me2 and
KC9me2 substitutions both resulted in significantly lower
SUV39H1 activity aswas previously observed for a K9me2
peptide (Rea et al., 2000). Consistent with this trend, a
KC9me1 peptide had an intermediate level of reactivity.
We conclude that the lysine analogs behave in a mannerfunctionally similar to natural lysine residues even in the
geometrically and chemically demanding context of an
enzymatic reaction important for epigenetic regulation.
To test if nucleosomes prepared from histones with
MLAs behave similarly to unmodified nucleosomes, salt
dialysis was used to assemble histone octamers into
end-positioned nucleosomes with DNA encoding a strong
positioning sequence (Lowary and Widom, 1998). The re-
sulting mononucleosomes were tested as substrates for
theATP-dependent remodelingcomplexhACF(Figure5B).
In the presence of ATP, hACF was able to remodel nucle-
osomes from their end position to a centered position on
the DNA (Figure 5C). It is not surprising that the methyl
Lys9 analogs have no apparent effect on the remodeling
reaction; even complete removal of the H3 N-terminal tails
does not substantially affect ACF activity (Eberharter et al.,
2001). Nonetheless, similar remodeling of unmodified and
MLA nucleosomes supports the conclusion that the
chemical manipulation required to construct MLA his-
tones does not have adverse effects on the histones, con-
sistent with the clean installation of MLAs observed by
mass spectrometry. Aside from the site of modification,Cell 128, 1003–1012, March 9, 2007 ª2007 Elsevier Inc. 1007
Figure 4. Methyl Lys9 Analogs Behave
Similarly to Their Natural Counterparts
in Binding Assays
(A) Based on the crystal structure of HP1
(green) bound to a K9me2 peptide (gray back-
bone, PDB:1KNA, from Jacobs and Khorasani-
zadeh [2002], a model of a KC9me2 peptide
(yellow backbone shown as overlay) bound to
HP1 was constructed and minimized using
MOLOC.
(B) Analysis of HP1a from 293 nuclear extracts
binding to immobilized H3 tail peptides. Pep-
tides (100 mg) with either unmodified lysine at
position 9 (K9), with natural dimethylation at
Lys9 (K9me2) or containing a dimethyl lysine
analog, KC9me2, were used as affinity reagents
and bound HP1a was monitored by western
blot. In (B)–(E), input represent 5% of the start-
ing nuclear extract.
(C) HP1a from nuclear extracts is specifically
enriched upon binding to immobilized nucleo-
somes (100 pmol) assembled with H3KC9me2
relative to unmodified nucleosomes (WT).
(D) SUZ12 is enriched when using both
KC9me2modified and unmodified (WT) nucleo-
somes as affinity reagents.
(E) DNMT1 does not pull down using either
KC9me2 modified or unmodified (WT) nucleo-
somes as affinity reagents.nucleosomes with MLAs appear similar to unmodified
nucleosomes in these assays.
While methylation at H3 K9 was not anticipated to affect
the rates of ACF or ISWI-family nucleosome remodelers,
H4 K20 is proximal to residues that interact with other
members of the ISWI family (Clapier et al., 2001; Clapier
et al., 2002; Hamiche et al., 2001). To test if trimethyaltion
at histone H4 residue 20 affects the rate of ACF mononu-
cleosome remodeling, we assembled end-positioned nu-
cleosomes with H4 KC20me3 and compared their rate of
ACF remodeling with that of wild-type nucleosomes under
conditions of excess and saturating ACF. In this assay, no
significant differences were observed (data not shown).
In efforts to uncover more subtle effects of KC20me3
on remodeling, we repeated the remodeling assay and
followed the progress of the reaction using a time course
(Figure 5D). No significant differences were observed
between the remodeling of H4 KC20me3 and wild-type
nucleosomes. These data suggest that, despite the prox-1008 Cell 128, 1003–1012, March 9, 2007 ª2007 Elsevier Inc.imity of histone H4 K20 to residues that influence ACF ac-
tivity, methylation at H4 K20 exerts its regulatory influence
by amechanism other than influencing themaximal rate of
ACF nucleosome remodeling. The MLA strategy will be
helpful for the investigation of other models connecting
K20 methylation to transcriptional repression.
In addition to the potential regulatory roles exerted
by posttranslational modifications of histone tails, it has
been suggested that modifications of residues in the
globular domains in the core of the nucleosomemay influ-
ence nucleosome stability or ATP-dependent nucleosome
remodeling (Cosgrove et al., 2004). The MLA approach
allows the generation of nucleosomes specifically methyl-
ated at core residues to test these hypotheses. For exam-
ple, we generated nucleosomes specifically dimethylated
at position 79 of histone H3 and tested whether or not
this modification affects the rate of remodeling by ACF.
End-positioned H3 KC79me2 nucleosomes were re-
modeled with similar rates as wild-type nucleosomes
Figure 5. Analysis of MLAs as Substrates in Enzymatic Assays
(A) The Lys9 methyltransferase activity SUV39H1 was examined using [3H-Me]-SAM and biotinylated H3 tail peptides (residues 1–14) containing
either unmodified lysine at position 9 (K), dimethyl lysine (K9me2), aminoethylcysteine (KC9), the monomethyl lysine analog (KC9me1), or the dimethyl
lysine analog (KC9me2). Data are shown as white bars for peptides with natural lysine residues and as gray bars for lysine analogs.
(B) Schematic depicting the assembly and hACF-mediated remodeling of positioned mononucleosomes.
(C) Similar levels of hACF-mediated ATP-dependent remodeling activity are observed using nucleosomes with or without MLAs. Upon native gel
electrophoresis, the migration of centrally positioned nucleomsomes is retarded relative to the migration of end-positioned nucleosomes.
(D) The maximal rate of ACF-mediated nucleosome remodeling is not affected by KC20me3 or KC79me2 as demonstrated in a remodeling assay
observed at several different time points.
(E) Graphical analysis of the results form (D) demonstrating similar rates of remodeling of wild-type and modified nucleosomes.(Figures 5D and 5E). In addition to demonstrating that
KC79me2 does not influence ACF remodeling under these
conditions, these results underscore the utility of MLA his-
tones to test nucleosome-level properties of methylated
nucleosomes (such as remodeling), especially nucleo-
somes methylated at residues within the globular core of
the nucleosome that are largely inaccessible by other
techniques such as native chemical ligation.
DISCUSSION
Understanding the impact of site-specific lysine mono-,
di-, and trimethylation on transcriptional regulation, devel-
opment and tumorigenesis requires biochemical analysis
of the effects of these modifications on chromatin struc-
ture and function. In some cases, the primary sequence
context immediately surrounding the site of methylation
appears sufficient to recapitulate a biochemical role for
the modification. In such cases, including the binding in-
teractions of H3 Lys9me to HP1a (Nakayama et al.,
2001) and Lys27me to Polycomb (Fischle et al., 2003;Min et al., 2003), peptides serve as useful models. In other
contexts, however, it is likely that the role of the modifica-
tion will require recognition elements present in the
nucleosome but not necessarily nearby in the primary se-
quence. This is particularly likely for core modifications.
Furthermore, for studies involving lysinemodifications that
directly affect nucleosome structure, mobility, or stability,
peptide models are not applicable. The need for the tech-
nology described here is made apparent by recent reports
demonstrating H3 Lys4 methylation functions, at least in
part, by directly recruiting remodeling factors (Wysocka
et al., 2006). Nucleosomes constructed using the MLA
approach are useful for testing the regulatory influence of
site-specific methylation on nucleosome-level biochemi-
cal activities, as we have demonstrated by testing the
effects of methylation at positions 9 and 79 of histone
H3 and position 20 of histone H4 on nucleosome remod-
eling (see Figures 5C, 5D, and 5E).
The MLA strategy described here provides an efficient
and economical route to large quantities of recombinant
methylated histones. The chemistry to install MLAs hasCell 128, 1003–1012, March 9, 2007 ª2007 Elsevier Inc. 1009
been optimized to allow clean conversion of cysteine res-
idues anywhere on the histones. The resulting analogs
are stable except that, likemethionine, they contain a thio-
ether and are therefore susceptible to oxidation (i.e., sulf-
oxide formation). Standard precautions to avoid oxidizing
conditions are sufficient to prevent these side reactions
(Figure S1B).
While MLAs differ from their natural counterparts by re-
placement of a methylene with a sulfide, we have found
that, similar to previous reports using aminoethylcysteine,
this perturbation causes minimal impact on function in
binding and enzymatic assays. While the extent to which
the MLAs mimic their natural counterparts will be context
dependent, we found that antibodies generated against
K9me1, K9me2, K9me3, K20me1, K4me3, K36me3,
and K79me2 all demonstrated specific recognition of
the appropriate analogs (Figure 3), albeit in one case
(i.e., K9me2) with approximately 5-fold lower activity
(Figure S3). Nonetheless, the success with antibodies
and the results from other functional assays support the
conclusion that MLAs serve as a general means to study
lysine methylation. For example, here, we examined the
binding of candidate effector proteins and probed the in-
fluence of site-specific methylation on ATP-dependent
nucleosome remodeling.
As the biochemical functions associated with each ly-
sine methylation are elucidated, it will become increas-
ingly important to study these modifications in combina-
tion. While the MLA strategy is not compatible with the
installation of different degrees ofmethylation on the same
histone subunit (e.g., H3 KC9me3/KC27me1), it is compat-
ible with the installation of the samemodification on differ-
ent sites (e.g., H3 KC4me3/KC27me3) or different modifi-
cations on different subunits (e.g., H3 KC27me3/H4
KC20me1).
The biochemical analysis of the regulatory impact of
specific histone lysine methylation marks has been largely
limited to studying methylated peptides outside the con-
text of nucleosomes. The MLA strategy facilitates the
study of these important epigenetic marks in the context
of nucleosomes. Ongoing studies include the use of
MLAs to further investigate the role of lysine methylation
in nucleosome remodeling studies, enzymatic assays,
structural studies, compaction assays, and in vitro tran-
scription, particularly with respect to understanding re-
pressive chromatin structures. Using the MLA strategy,
proteins bearing specific methylation are straightforward
to generate; their broad use will aid in studying the events
downstream of lysine methylation, thereby expanding our
understanding of the biochemical mechanisms underlying
epigenetic regulation.
EXPERIMENTAL PROCEDURES
Histones, Octamers, and Nucleosomes
Xenopus histones were expressed in E. coli and purified via gel filtra-
tion as previously described (Luger et al., 1997, 1999). All histone H3
constructs contain a C110A mutation, including those labeled as1010 Cell 128, 1003–1012, March 9, 2007 ª2007 Elsevier Inc.wild-type here. Lys-to-Cys mutants constructed using Quikchange
mutagenesis (Stratagene) according to the manufacturer’s instruc-
tions. Histone octamers and nucleosomes were assembled according
to previous reports (Luger et al., 1997, 1999). The DNA used for the as-
sembly of mononucleosomes included the Widom 601 positioning se-
quence (Lowary and Widom, 1998) with 49 bp of additional DNA and
was constructed by PCR using biotinylated and Cy3-labeled primers.
Nucleosomes constructed using MLA histones were purified and
stored in the presence of 1 mM tris(2-carboxyethyl)phosphine hydro-
chloride (TCEP).
Peptide Synthesis and Alkylation
Peptides were synthesized using Fmoc-protected amino acids ac-
cording to standard methods. Fluoresceine-mPEG-GACR-OH, where
Fl is Fluoresceine and mPEG is an ethylene glycol linker (building
block: Fmoc-mini-PEG, Peptides International) and Biotin-mPEG-
ARTKQTARXSTGGK-OH, where X is either cysteine, lysine, or di-
methyl lysine as indicated. For peptide alkylations, HPLC-purified pep-
tides were dissolved in guanidinium chloride (10 ml, 8 M) and diluted
with HEPES buffer (For KC[me1] and KC[me2]: 85 ml, 1 M, pH 8; for
KC[me3] 88 ml, 1 M, pH 7.5) and DTT (2 ml of 1 M, dissolved immediately
before use). The peptides were reduced for 1 hr at 37C. Alkylating
agents were added as follows. For KC(me1), (2-chloroethyl)-methylam-
monium chloride (1, Karl Industries, Inc.) was added (10 ml of 3 M, dis-
solved immediately before use) and the reaction was allowed to pro-
ceed for 4h. DTT was added (1 ml of 1 M) and after 30 min at rt, more
alkylating agent was added (10 ml of 3 M). The reaction was allowed
to proceed for 12 hr. For KC(me2), (2-chloroethyl)-dimethylammonium
chloride (2, Aldrich) was added (10 ml of 1M, dissolved immediately be-
fore use), and the reaction was allowed to proceed for 2 hr. DTT was
added (1 ml of 1 M) and, after 30 min at room temperature, additional
2 was added (10 ml of 1 M). The reaction was then allowed to proceed
for 2 hr. For KC(me3), (2-bromoethyl) trimethylammonium bromide
(3, Aldrich) was added as a solid (10 mg), and the reaction was heated
to 50C in the dark. With occasional mixing, the solid dissolved slowly.
After 2 hr, DTT was added (1 ml of 1M), and the reaction was allowed to
proceed for another 2 hr at 50C. In all cases, the reactions were
quenched with BME (5 mL, 14.2 M) and then analyzed or purified
from the reaction mixture by analytical RP HPLC (A = H2O with 0.1%
TFA; B = MeCN with 0.1% TFA). For HPLC of Fluoresceine-labeled
peptides, absorbance was monitored at 430 nm. The identities of the
products were confirmed by MALDI-TOF MS.
Installation of MLAs into Full-Length Proteins
Lyophilized histones (5–10 mg) were dissolved in alkylation buffer (1 M
HEPES pH 7.8, 4 M guanadinium chloride, 10 mM D/L-methionine; for
KC[me1], 900 mL; for KC[me2], 930 mL; for KC[me3], 980 ml), and DTT
was added (20 ml of 1 M, dissolved immediately before use). The his-
tones were reduced for 1 hr at 37C. Alkylating agents were added
as follows. All reactions were performed in the dark. For KC(me1), 1
was added (100 ml of 1 M, dissolved immediately before use), and
the reaction was allowed to proceed for 4 hr at room temperature.
DTT was added (10 ml of 1M), and the reaction was allowed to proceed
for at least 10 hr at room temperature. For KC(me2), 2was added (50 ml
of 1 M, dissolved immediately before use), and the reaction was al-
lowed to proceed for 2 hr at room temperature. Then, DTT was added
(10 ml of 1 M), the reaction incubated at room temperature for 30 min,
treated with additional 2 (50 mL, 1 M) and allowed to proceed for an ad-
ditional 2 hr at room temperature. For KC(me3), 3was added as a solid
(100 mg), and the reaction was heated to 50C. With occasional mix-
ing, the solid slowly dissolved. After 2.5 hr, DTT was added (10 ml of
1 M), and the reaction was allowed to proceed for another 2.5 hr at
50C. In all cases, the reactions were quenched with BME (50 mL,
14.2 M) and then purified from the reaction mixture using PD-10 col-
umns pre-equilibrated with BME/H2O (3 mM). The concentration of
the eluant was quantified using a protein concentration assay
(BioRad), and the histones were aliquoted, lyophilized, and stored as
frozen pellets.
Mass Spectrometry
Mass spectrometry was performed on the following instruments.
Peptides were analyzed on an ABI Voyager Elite MALDI-TOF using
a-cyano-4-hydroxycinnamic acid as matrix. Routine analysis of MLA
reactions was preformed using a Waters Micromass LCT premire.
For more comprehensive analysis, the intact histones were analyzed
on a 7-tesla hybrid linear ion trap (LTQ FT) mass spectrometer (Thermo
Electron Corp., Palo Alto, CA) with a nanoelectrospray ion source at a
concentration of 5 pmole/ml. ECD spectra were acquired with a res-
olution of 100,000 and an isolation window of m/z 20. The activation
and delay time in ECD were 5 ms and 8 ms. FT transients were accu-
mulated, and ECD fragment ions were assigned using the Fragment
Assignment by Visual Assistance (FAVA) algorithm in the MATLAB
environment.
Nucleosome-Remodeling Assays
Analysis of nucleosome remodeling by recombinant hACF was
performed essentially as described (He et al., 2006). Briefly, reactions
(10 mL) were performed in 12% glycerol, 60 mM KCl, 12 mM
HEPES, 4 mM Tris, 3 mM MgCl2, 0.32 mM EDTA, 0.02% NP-40, and
0.4 mg/mL FLAG peptide (Strohner et al., 2005). Mononucleosomes
(20 nM) assembled using Cy3-labeled DNA with the Widom 601 posi-
tioning sequence (Lowary and Widom, 1998), and 49 bp additional
DNA were incubated with recombinant hACF (25 nM). Reactions
were started with MgATP (2 mM) and incubated at room temperature
for 30min before addition of stop buffer (2 mL, 0.8mg/mL plasmidDNA,
and 115 mM ADP). The entire 12 ml reaction was analyzed by native
PAGE (5% acrylamide, 0.5X Tris borate-EDTA gel, 2 hr, 100 V), and
the Cy3 fluorescence of the gel was visualized on an Amersham
Typhoon 9400 variablemode imager at 580 nm. The time course exper-
iments were performed similarly except the reactions were performed
using subsaturating concentrations of ATP (4 mM MgATP, see Yang
et al., 2006), and the reactions were incubated at 30C.
Affinity Studies
Nuclear extracts were prepared from 293 cells according to (Dignam
et al., 1983) and then precleared with strepavidin-coated magnetic
beads (1 mg beads per mL extract, Dynal M270). Biotinylated peptides
(100 mg) or biotinylated nucleosomes (100 pmol) were diluted to 100 ml
with wash buffer (100 mM KCl, 5 mMMgCl2, 20 mM HEPES at pH 7.6,
5% glycerol, 0.1 mg/mL BSA) and incubated with prewashed strepa-
vidin-coated magnetic beads (0.5 mg) for 30 min with mixing. The
beads were washed three times with wash buffer. The precleared nu-
clear extract was added (20 mL), and the bead suspension was mixed
for 1 hr at 4C. The beads were captured, the supernatant was aspi-
rated, and the beads rinsed three times with wash buffer. The bound
material was eluted with loading buffer, boiled for 5 min, resolved by
denaturing PAGE (5%–20%), transferred to a PVDF membrane, and
analyzed by western blot.
Coimmunoprecipitation and HMTase Assays
Human SUV39H1 cDNA was cloned by PCR from HEK293 cDNA, ver-
ified by sequencing, and subsequently fused to a GFP tag in the
pEGFP-C3 vector (Clontech). The plasmid was transfected into
HEK293 cells (5 3 106/10-cm plate) using FuGENE6 (Roche Applied
Science) according tomanufacturer’s conditions. Forty-eight hours af-
ter transfection, HEK293 cells were processed for coimmunoprecipita-
tion as described (Chu et al., 2006). The immunoprecipitation reactions
were performed at 4C overnight. The resulting immunoprecipitates
were then subjected to HMTase assays essentially as described (Rea
et al., 2000). S-Adenosyl-L-(methyl-3H) Methionine (74.0 Ci/nmol,
Amersham) was used as the methyl donor, and 4 mg of biotinylated
N-terminal peptides were used as the substrate. After the HMTase
assay, peptides were spotted onto SAM2 Biotin Capture Membranes(Promega), washed, and subjected to scintillation counting as de-
scribed (Lindroth et al., 2004).
Supplemental Data
Supplemental Data include three figures, Supplemental Experimental
Procedures, and Supplemental References and can be found with
this article online at http://www.cell.com/cgi/content/full/128/5/1003/
DC1/.
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